###begin article-title 0
A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells
###end article-title 0
###begin p 1
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
###end p 1
###begin p 2
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 254 264 254 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1/KRIT1</italic>
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM2</italic>
###xml 274 285 274 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM3/PDCD10</italic>
###xml 309 312 309 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM</italic>
Cavernous vascular malformations occur with a frequency of 1:200 and can cause recurrent headaches, seizures and hemorrhagic stroke if located in the brain. Familial cerebral cavernous malformations (CCMs) have been associated with germline mutations in CCM1/KRIT1, CCM2 or CCM3/PDCD10. For each of the three CCM genes, we here show complete localized loss of either CCM1, CCM2 or CCM3 protein expression depending on the inherited mutation. Cavernous but not adjacent normal or reactive endothelial cells of known germline mutation carriers displayed immunohistochemical negativity only for the corresponding CCM protein but not for the two others. In addition to proving loss of function at the protein level, our data are the first to demonstrate endothelial cell mosaicism within cavernous tissues and provide clear pathogenetic evidence that the endothelial cell is the cell of disease origin.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM2</italic>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM3</italic>
###xml 517 518 517 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C1">1</xref>
###xml 519 520 519 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C2">2</xref>
###xml 717 718 717 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C3">3</xref>
###xml 905 909 905 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 1079 1083 1079 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 1112 1116 1112 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 1144 1145 1144 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C4">4</xref>
###xml 1173 1177 1173 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 1274 1275 1274 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C5">5</xref>
###xml 1284 1288 1284 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 1511 1514 1511 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1521 1526 1521 1526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1635 1636 1635 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C6">6</xref>
###xml 1637 1638 1637 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C8">8</xref>
###xml 1770 1774 1770 1774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 1599 1604 <span type="species:ncbi:9606">human</span>
###xml 1609 1615 <span type="species:ncbi:10090">murine</span>
Cerebral cavernous malformations (CCMs) are vascular lesions causing chronic headaches, seizures and hemorrhagic stroke. Autosomal dominantly inherited forms occur with a frequency of 1:2000 to 1:10 000 and are associated with germline mutations in one of at least three genes, CCM1, CCM2 or CCM3. The occurrence of multiple CCMs in most hereditary cases but only single CCM in the majority of sporadic cases has led to the notion that biallelic mutations within the same gene are required for the formation of CCMs (1,2). Such a 'two-hit' disease mechanism has been supported by the observation that slowly enlarging CCMs may develop as late sequelae of cranial radiation therapy within fields of prior irradiation (3). However, a two-hit model of CCM genesis that assumes inactivation of both alleles of a given CCM gene within affected cells has been difficult to prove. Biallelic germline and somatic CCM1 mutations have thus far only been reported once. Tissue pieces from the middle part of a single cavernous lesion harbored a somatic 34 bp deletion within exon 15 of the CCM1 gene in addition to a known CCM1 germline founder mutation (4). Furthermore, two somatic CCM1 missense mutations were found in a singular lesion of an individual affected with sporadic CCM (5). While CCM1 mutations are generally truncating or result from large genomic rearrangements, the functional relevance of these two missense mutations remained unclear. It could also not be determined whether the two mutations occur in cis or in trans. Several other groups have been unable to identify somatic mutations in human and murine cavernous tissues (6-8). This may have been due to the application of insensitive genetic screening techniques given that direct sequencing revealed many CCM1 gene mutations that had been missed by denaturing high-performance liquid chromatography or SSCP in the past.
###end p 5
###begin p 6
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C9">9</xref>
A further explanation for the difficulties to prove the two-hit model relates to the nature of the CCM tissue. Blood-filled, often thrombosed and re-organized cavities are lined by extremely thin endothelial cells that are separated by abundant collagenous connective tissue containing a mixture of different cell types (9). A putative second mutation could be envisioned to occur only in a small subset of cells and, therefore, may remain undiscovered during genetic screening.
###end p 6
###begin p 7
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 79 80 79 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C5">5</xref>
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C10">10</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C11">11</xref>
###xml 133 136 133 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM</italic>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C12">12</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C13">13</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C14">14</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C15">15</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C16">16</xref>
###xml 827 831 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ccm1</italic>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C17">17</xref>
###xml 796 805 <span type="species:ncbi:7955">zebrafish</span>
Currently, the cell of disease origin is still unknown. In situ hybridization (5,10) and immunohistochemical studies (11) have shown CCM transcript and protein expression in endothelial and various non-endothelial cell types such as neurons and astrocytes. Notably, cavernous malformations do not only occur in the brain but occasionally also in the skin (12) and consist of endothelial cells with slight proliferative tendency (13) and lack of endothelial tight junctions (14,15) that stain positively with anti-CCM1 antibodies in cell culture (16). Such morphologically altered, extremely thin vascular endothelial cells lining the caverns appear to be the primary disease compartment that needs to be dissected and analyzed. This approach is supported by recent transplantation experiments in zebrafish that have shown that ccm1 cell autonomously regulates endothelial cellular morphology (17).
###end p 7
###begin p 8
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C16">16</xref>
###xml 251 255 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM2</italic>
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM3</italic>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 118 123 <span type="species:ncbi:9606">human</span>
The present study demonstrates that a previously generated anti-human CCM1 antibody (16) and two newly generated anti-human CCM2 and CCM3 antibodies are immunohistochemical markers for the vascular endothelium. CCM tissues from individuals with known CCM1, CCM2 or CCM3 germline mutations revealed that immunohistochemical negativity of the corresponding CCM protein is the hallmark of vascular endothelial cells lining pathological caverns. Lack of immunoreactivity of the respective CCM protein in cavernous endothelial cells provides strong evidence for the two-hit hypothesis of CCM formation and underscores the concept of morphologically abnormal endothelial cells lining caverns as targets of disease origin. In addition, our studies reveal that the detection of loss-of-heterozygosity in CCM endothelial cells is complicated by both low number of mutated cells and the fact that the vascular endothelium within a single CCM tissue is mosaic for wild-type and mutant endothelial cells.
###end p 8
###begin title 9
RESULTS
###end title 9
###begin title 10
Variable expression of CCM proteins in normal brain vascular endothelium
###end title 10
###begin p 11
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F1">1</xref>
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F1">1</xref>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F1">1</xref>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F1">1</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C16">16</xref>
###xml 667 668 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F2">2</xref>
###xml 743 744 743 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F2">2</xref>
###xml 777 778 777 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F2">2</xref>
###xml 1162 1163 1162 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F2">2</xref>
###xml 1270 1274 1270 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM2</italic>
###xml 1307 1308 1307 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F2">2</xref>
###xml 1444 1445 1444 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F2">2</xref>
###xml 1582 1583 1582 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F2">2</xref>
###xml 1680 1681 1680 1681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F2">2</xref>
###xml 1804 1805 1804 1805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F2">2</xref>
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 115 120 <span type="species:ncbi:9606">human</span>
###xml 137 142 <span type="species:ncbi:9606">human</span>
###xml 152 158 <span type="species:ncbi:10090">murine</span>
###xml 238 243 <span type="species:ncbi:9606">human</span>
###xml 559 564 <span type="species:ncbi:9606">human</span>
The newly generated anti-human CCM3 antibody reacts specifically with a fragment of the size of 25 kDa recombinant human CCM3 in various human cell and murine tissue lysates (Fig. 1A) and with CCM3 peptide MIERPEPEFQDLNEK (Fig. 1B). Anti-human CCM2 recognizes overexpressed CCM2 (Fig. 1C) as well as several CCM2 epitopes (Fig. 1D) but could only be used in high concentrations that yielded strong background in most western blots with cell and tissue lysates. Immunohistochemistry demonstrated that both antibodies and a polyclonal but not a monoclonal anti-human CCM1 antibody (16) stained vascular endothelium of venous, arterial and capillary blood vessels (Fig. 2). The CCM1 antibody demonstrated immunoreactivity in both meningeal (Fig. 2A) and parenchymal vessels (Fig. 2B). We observed large differences of the staining intensity for CCM1 among the endothelia of different normal brain vessels and within the meninges. Parenchymal capillary endothelia with broadened walls were often stained, whereas vessels with narrow walls regularly showed no immunoreactivity. Moreover, brain tissue cells resembling microglia revealed strong immunoreactivity (Fig. 2C). This correlated well to the strong staining of foamy macrophages in the vicinity of a cavernoma from a CCM2 germline mutation carrier (Fig. 2D). The antibody against CCM2 revealed granular staining of capillary vessels throughout the brain parenchyma and in the meninges (Fig. 2E and F). The antibody against CCM3 showed a staining pattern similar to CCM1. Most vessel endothelia were labeled by the antibody (Fig. 2G). However, there were thin-walled vessels that showed merely weak or no immunoreactivity (Fig. 2F and G). In addition, the CCM3 antibody detected polymorphonuclear blood cells and Purkinje cells in the cerebellum (Fig. 2G and H).
###end p 11
###begin p 12
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 127 128 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">coli</italic>
###xml 496 497 496 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 534 536 534 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 550 551 550 551 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 637 638 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">coli</italic>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C18">18</xref>
###xml 790 791 790 791 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 828 830 828 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 127 134 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 161 166 <span type="species:ncbi:9606">human</span>
###xml 176 182 <span type="species:ncbi:10090">murine</span>
###xml 206 211 <span type="species:ncbi:9606">human</span>
###xml 252 257 <span type="species:ncbi:9606">human</span>
###xml 297 302 <span type="species:ncbi:9606">human</span>
###xml 343 348 <span type="species:ncbi:9606">human</span>
###xml 569 574 <span type="species:ncbi:9606">human</span>
###xml 612 617 <span type="species:ncbi:9606">human</span>
###xml 637 644 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
(A) Polyclonal anti-human CCM3 antibody specifically reacts with a protein of the size of recombinant human CCM3 purified from E. coli (lane 1) in the indicated human cell and murine tissue lysates (HUVEC, human umbilical vein endothelial cells; HMEC, human microvascular endothelial cells; HeLa, human epitheloid cervix carcinoma cells; 293, human embryonal kidney cell line). Ten micrograms of lysates was separated on 10-20% polyacrylamide-SDS gradient gels and analyzed by western blotting. (B) CCM3 epitope mapping using PepSpotsTM technology. (C) Polyclonal anti-human CCM2 antibody recognizes recombinant human CCM2 purified from E. coli, HA-tagged CCM2 as well as HA-tagged CCM2:p.P11_K68del (18) overexpressed in 293 cells and a protein of the size of CCM2 in lymphocyte lysates. (D) CCM2 epitope mapping using PepSpotsTM technology. Peptide 11 resides within the PTB domain making cross-reactivity likely. Peptide 56 was artificially modified and corresponds to peptide 34.
###end p 12
###begin p 13
###xml 52 53 52 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 248 249 248 249 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 398 399 398 399 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 416 417 416 417 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 477 478 477 478 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 565 566 565 566 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 625 626 625 626 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 631 632 631 632 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
###xml 603 608 <span type="species:ncbi:9606">human</span>
###xml 706 711 <span type="species:ncbi:9606">human</span>
Expression of CCM proteins in human brain tissues. (A) Polyclonal anti-human CCM1 antibody stains vascular endothelia (arrowheads) in normal meningeal tissues. The asterisks indicate an adjacent blood vessel with immunonegative endothelial cells. (B) Stronger (arrowhead) and weaker (asterisk) staining intensities with the anti-CCM1 antibody in parenchymal vessels. The CCM1 antibody also stains (C) microglia and (D) foamy macrophages in the vicinity of a cavernous lesion. (E) Granular staining of capillary vessels in the brain parenchyma (E) and the meninges (F) incubated with the polyclonal anti-human CCM2 antibody. (G and H) Positive immunoreactivity of vessel endothelia with the polyclonal anti-human CCM3 antibody which also detected (G) polymorphonuclear blood cells (arrow) and (H) Purkinje cells (arrow) in the cerebellum. (G) Similar to anti-CCM1, anti-CCM3 shows different staining intensities for endothelia of vessels with broadened walls (arrow head) when compared with adjacent thin-walled vessels (asterisk).
###end p 13
###begin title 14
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM</italic>
Absence of CCM immunoreactivity in endothelial cells lining pathological caverns correlates with the respective CCM germline mutation
###end title 14
###begin p 15
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDN420TB1">1</xref>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDN420TB1">1</xref>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F3">3</xref>
###xml 501 502 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F3">3</xref>
###xml 744 748 744 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 783 784 783 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDN420TB1">1</xref>
###xml 950 958 950 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 960 962 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C18">18</xref>
###xml 1019 1020 1019 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDN420TB1">1</xref>
###xml 152 159 <span type="species:ncbi:9606">patient</span>
###xml 652 657 <span type="species:ncbi:9606">human</span>
Markedly reduced to absent CCM1 immunostaining in endothelial cells lining pathological caverns was observed for cavernous endothelia analyzed from one patient carrying a CCM1 germline mutation (No. 1, Table 1, ). Within the cavernous lesion of a second individual with a CCM1 germline mutation (No. 2, Table 1), a subset of presumably neoangiogenic vessels was labeled with the anti-CCM antibody (Fig. 3A) while endothelia lining large pristine caverns were found to be immunonegative for CCM1 (Fig. 3B). For this familial case 2, adjacent brain tissue was available, which demonstrated prominent staining of normal arterial endothelium with the anti-human CCM1 antibody on the same tissue section (data not shown). Caverns analyzed from both CCM1 germline mutation carriers (Table 1, Nos 1 and 2) showed positive immunostaining for CCM2 and CCM3 (). Consistent with our recent finding that expression of CCM1:p.A715VfsX14 is reduced but not absent in vitro (18), even pristine caverns from sporadic case No. 3 (Table 1) demonstrated weak immunoreactivity ().
###end p 15
###begin p 16
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM</italic>
###xml 207 208 207 208 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 229 230 229 230 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 329 333 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 399 400 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDN420TB1">1</xref>
###xml 419 420 419 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 433 434 433 434 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 473 474 473 474 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 515 519 515 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM2</italic>
###xml 563 564 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDN420TB1">1</xref>
###xml 621 622 621 622 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 684 685 684 685 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 690 691 690 691 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 772 773 772 773 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 825 829 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM3</italic>
###xml 877 878 877 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDN420TB1">1</xref>
###xml 924 925 924 925 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J</bold>
###xml 953 954 953 954 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</bold>
###xml 959 960 959 960 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</bold>
###xml 177 182 <span type="species:ncbi:9606">human</span>
###xml 594 599 <span type="species:ncbi:9606">human</span>
Serial sections from carriers of a known germline mutation in one of the three CCM genes immunostained for CCM1, CCM2 and CCM3, respectively. Immunohistochemistry with the anti-human CCM1 antibody revealed (A) CCM1-positive and (B) CCM1-negative endothelia (arrowheads) within the same cavernous malformation tissue section of a CCM1:c.1780_1783delinsTACCTGTTACCAAA germline mutation carrier (Table 1, No. 2), whereas (C) CCM2- and (D) CCM3-immunoreactivity was observed. (E) Normal brain arterial endothelium of a CCM2:c.30+1G>A germline mutation carrier (Table 1, No. 4) reacts with the anti-human CCM2 antibody while (F) cavernous endothelium in the same tissue section does not. (G and H) Immunostaining for CCM1 and CCM3 is positive in caverns from this individual. (I) Vessels in revascularized thrombosed caverns of a CCM3:c.350_351insT germline mutation carrier (Table 1, No. 7) show CCM3-immunoreactivity, whereas (J) pristine caverns do not. (K and L) Positive immunostaining for CCM1 and CCM2 in the same cavernous lesion. Scale bar in (A): 100 microm, in (E): 20 microm, all others: 50 microm. Insets in (C) and (L) demonstrate faint granular immunoreactivity for CCM2, whereas the inset in (F) shows negativity for CCM2 at five times higher magnification (original magnification 100x).
###end p 16
###begin p 17
Overview of CCM endothelial cell immunohistochemistry and respective germline mutations
###end p 17
###begin p 18
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM2</italic>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM3</italic>
IH, immunohistochemistry of CCM endothelial cells. Nos 5 and 6 are siblings. GenBank accession nos are: CCM1: NM_194456.1, CCM2: NM_031443.3, CCM3: NM_007217.3. DNA mutation numbering is based on cDNA sequence with +1 corresponding to the A of the ATG translation initiation codon.
###end p 18
###begin p 19
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aImmunonegative pristine caverns plus immunoreactive endothelial cells within same CCM lesion, the latter most likely representing neoangiogenic vessels derived from vessels with only the germline mutation.
###end p 19
###begin p 20
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 134 142 134 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C18">18</xref>
bPartial immunoreactivity in pristine caverns corresponding to the fact that CCM1:p.A715VfsX14 was shown to be reduced but not absent in vitro (18).
###end p 20
###begin p 21
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM2</italic>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM2</italic>
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDN420TB1">1</xref>
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F3">3</xref>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F3">3</xref>
###xml 494 498 494 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM2</italic>
###xml 583 584 583 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F3">3</xref>
###xml 411 416 <span type="species:ncbi:9606">human</span>
###xml 546 551 <span type="species:ncbi:9606">human</span>
Immunohistochemical negativity of cavernous endothelial cells from three carriers of CCM2 germline mutations that are all located near the 5' end of the CCM2 gene (Table 1, Nos 4-6) was consistent with defective CCM2 protein expression in all cavernous endothelia assessed (Fig. 3F, ). In contrast, regular brain arterial endothelium (available for individual Nos 4 and 5) showed immunoreactivity with the anti-human CCM2 antibody (Fig. 3E). As expected, cavernous endothelium from carriers of CCM2 germline mutations stained positively for anti-human CCM1 and CCM3 antibodies (Fig. 3G and H, ).
###end p 21
###begin p 22
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM3</italic>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C18">18</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C19">19</xref>
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM3</italic>
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDN420TB1">1</xref>
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F3">3</xref>
###xml 415 416 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F3">3</xref>
###xml 480 484 480 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM3</italic>
###xml 561 562 561 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F3">3</xref>
###xml 153 161 <span type="species:ncbi:9606">patients</span>
###xml 389 394 <span type="species:ncbi:9606">human</span>
CCM3 mutations are known to account for only 10% of CCM mutations (18,19). The only individual with a germline mutation in the CCM3 gene in our panel of patients (Table 1, No. 7) showed absent CCM3 expression in cavernous endothelial cells (Fig. 3J), whereas capillary endothelial cells of vessels in revascularized thrombosed caverns within the same tissue sections reacted with the anti-human CCM3 antibody (Fig. 3I). Again, endothelial cells lining pathological caverns of the CCM3 germline mutation carrier revealed immunoreactivity for CCM1 and CCM2 (Fig. 3K and L).
###end p 22
###begin p 23
###xml 431 434 431 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM</italic>
Taken together, negative immunostaining of the corresponding CCM protein in endothelia from CCM tissues harboring a germline mutation suggests that the antibodies tested specifically stain the corresponding CCM1, CCM2 or CCM3 proteins. Furthermore, our data underline that CCM pathology is primarily due to defective endothelial cells. Most importantly, complete and specific lack of CCM protein in affected endothelial cells from CCM germline mutation carriers supports a genetic two-hit mechanism for CCM formation.
###end p 23
###begin title 24
Technical limitations of genetic proof of two-hit mechanism
###end title 24
###begin p 25
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F3">3</xref>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDN420TB1">1</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C20">20</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C21">21</xref>
###xml 471 474 471 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM</italic>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C18">18</xref>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C22">22</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C23">23</xref>
For molecular analyses, about 200 morphologically pathological endothelial cells (as seen in Fig. 3B) from each of three small heterogeneous CCM1-3 tissues (Table 1, Nos 2, 4 and 7) were sampled by laser-assisted microdissection in order to circumvent allele drop-out problems. Whole genome amplification (WGA) of the isolated DNA was performed by improved primer extension pre-amplification PCR (I-PEP-PCR) (20,21). Subsequent amplification and direct sequencing of the CCM gene for which a germline mutation (18,22,23) and negative CCM protein expression had been found revealed that only a subset of exons could be amplified most likely due to fragmentation of the DNA in the archival paraffin-embedded tissues. These amplification products did not reveal a second somatic mutation.
###end p 25
###begin title 26
DISCUSSION
###end title 26
###begin p 27
###xml 15 31 15 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG/ACVRL1/RASA1</italic>
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIE2</italic>
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">glomulin</italic>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM2</italic>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCCM3</italic>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIE2</italic>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C24">24</xref>
###xml 569 577 569 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">glomulin</italic>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C25">25</xref>
###xml 1089 1093 1089 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 1340 1341 1340 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C4">4</xref>
###xml 1545 1546 1545 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F3">3</xref>
###xml 1689 1693 1689 1693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIE2</italic>
###xml 1757 1759 1757 1759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C26">26</xref>
Arteriovenous (ENG/ACVRL1/RASA1), venous (TIE2), glomuvenous (glomulin) and cavernous (CCM1, CCM2, CCCM3) malformations are localized defects of vascular development that have been associated with autosomal dominantly inherited heterozygous germline mutations. Apart from TIE2 mutations, all are thought to cause loss of function (24). Paradominant inheritance was first shown for glomuvenous malformations (GVMs), which are characterized by abnormally differentiated smooth muscle cells in the walls of distented venous channels. A somatic 5 bp deletion in the second glomulin allele was identified in only one out of seven resected fresh-frozen lesions from different individuals by SSCP and heteroduplex analyses followed by sequencing of the cloned amplification product. It was concluded that cellular heterogeneity of GVMs limits somatic mutation detection (25). Similarly, a subtle denaturing high-performance liquid chromatography change in only two out of three samples from one surgically excised CCM lesion led to the identification of a biallelic somatic 34 bp deletion in the CCM1 gene. Peak heights suggested that 13.5-21% of DNA derived from an unknown cell type in the middle of the lesion carried the mutation, whereas the mutation-negative sample from the lesion margin might have been largely composed of normal vessels (4). Our data define cavernous endothelial cells as the primary disease compartment and suggest that the mutation-negative vessels might correspond to immunopositive neoangiogenic vessels as seen in Figure 3I. In a recent systematic study of fresh-frozen venous malformation tissues, single and double-hit mutations in the angiopoietin-receptor gene TIE2 were found to cause both solitary and multiple sporadic forms (26).
###end p 27
###begin p 28
###xml 1502 1504 1502 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C20">20</xref>
###xml 1706 1708 1706 1708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C27">27</xref>
###xml 1709 1711 1709 1711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C30">30</xref>
###xml 874 882 <span type="species:ncbi:9606">patients</span>
In contrast to the venous and glomuvenous skin lesions, CCMs are less accessible and often resected at late stages after recurrent bleeding. In addition, microsurgical excision is performed by the dissection of the vessel to brain interlayer. During the excision, the cavernous lesion itself and the feeding and draining vessels are permanently shrinked by electrosurgical coagulation. Thus, the CCM tissue is often primarily thrombosed, reorganized, calcified and always artificially altered by the surgical manipulation. Furthermore, endothelial cells lining pristine caverns only represent a small subset of cells. Therefore, DNA must be purified from small amounts of laser-microdissected starting material and pre-amplified by WGA to enrich mutant cells. When implementing WGA in our laboratory, only archival paraffin-embedded tissues were available for our cohort of patients. Compared with frozen sections, the quality of cell morphology for immunohistochemistry and laser microdissection is superior. However, fixation and staining procedures as well as sampling and storage conditions are known to compromise the integrity of the DNA and present a challenge for molecular analyses. Several WGA techniques are not suitable for use with formalin-fixed, paraffin-embedded clinical samples due to fragmentation of the template genomic DNA. For paraffin-embedded tissue sections, I-PEP-PCR was previously shown to yield the most efficient downstream amplification results after pre-amplification (20) but did not lead to detection of mutations in our tissue samples. Thus, the nature of the second-hit event remains unknown and potentially includes small mutations, large inactivating gene deletions (27-30), epigenetic as well as (post-)transcriptional pathomechanisms.
###end p 28
###begin p 29
###xml 64 65 64 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F3">3</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C13">13</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C31">31</xref>
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 804 805 804 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F3">3</xref>
###xml 1280 1281 1280 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN420F3">3</xref>
###xml 382 387 <span type="species:ncbi:9606">human</span>
Endothelial cell mosaicism within CCM tissues as seen in Figure 3A and I represents a further problem for molecular analyses. CCMs have been characterized as hamartomatous since they are benign, disorganized lesions with growth potential as a result of proliferative capacity and hemodynamic modifications. Endothelial proliferation and neoangiogenesis has been demonstrated within human CCM specimens by immunohistochemical staining for proliferating cell nuclear antigen (PCNA) and various vascular markers (13,31). Notelet et al. distinguished between areas with collagenous, thick-walled caverns and very few PCNA-stained endothelial cells and 'territories showing irregular, dilated, closely contiguous vascular spaces separated by lacy walls often with stained endothelial cells' as seen in Figure 3B or L. They also noted thrombi with figures of revascularization that contained PCNA-positive cells as well as staining of endothelial cells in capillaries at the periphery of these lesions and reactive glial cells, endothelial cells and pericytes in the surrounding brain parenchyma. Thus, the majority of activated proliferating endothelia within CCM tissues appears to be reactive and to correspond to the CCM-immunopositive neoangiogenic vessels seen in our study (Fig. 3A and I).
###end p 29
###begin p 30
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C17">17</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C16">16</xref>
###xml 554 558 554 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIE2</italic>
###xml 560 563 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM</italic>
###xml 568 576 568 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">glomulin</italic>
###xml 23 32 <span type="species:ncbi:7955">zebrafish</span>
Experimental data from zebrafish knockdown and knockout studies suggest alterations in endothelial cell morphology rather than endothelial cell proliferation as likely pathomechanism (17). We have observed that thick-walled thrombosed caverns often even lack endothelial cells at the cavernous wall (data not shown). It is conceivable that biallelic loss of a CCM-coding gene might affect other than tumor suppressor functions of CCM interactors like RAPIA, e.g. regulation of endothelial cell-cell junctions (16). Therefore, somatic inactivation of the TIE2, CCM and glomulin genes suggests that the Knudsonian two-hit mechanism may not be limited to a classic tumor suppressor model but also plays a pivotal role in the pathogenesis of these non-neoplastic vascular malformations.
###end p 30
###begin title 31
MATERIALS AND METHODS
###end title 31
###begin title 32
###xml 33 38 <span type="species:ncbi:9606">human</span>
Generation of antibodies against human CCM2 and CCM3
###end title 32
###begin p 33
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM2</italic>
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM3</italic>
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 85 99 85 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cherichia coli</italic>
###xml 1770 1777 1761 1768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 1812 1823 1803 1814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Danio rerio</italic>
###xml 1889 1891 1880 1882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 83 111 <span type="species:ncbi:511693">Escherichia coli strain BL21</span>
###xml 599 604 <span type="species:ncbi:9606">human</span>
###xml 619 624 <span type="species:ncbi:9606">human</span>
###xml 677 684 <span type="species:ncbi:9986">rabbits</span>
###xml 699 704 <span type="species:ncbi:9606">human</span>
###xml 1022 1027 <span type="species:ncbi:9606">human</span>
###xml 1738 1743 <span type="species:ncbi:9606">human</span>
###xml 1745 1751 <span type="species:ncbi:10090">murine</span>
###xml 1753 1756 <span type="species:ncbi:10116">rat</span>
###xml 1758 1765 <span type="species:ncbi:9031">chicken</span>
###xml 1770 1777 <span type="species:ncbi:8355">Xenopus</span>
###xml 1812 1823 <span type="species:ncbi:7955">Danio rerio</span>
Full-length human CCM2 and CCM3 genes were cloned into pET28b and overexpressed in Escherichia coli strain BL21 (DE3), respectively. Highly purified protein samples were obtained by IMAC capture of His-tagged fusion proteins using Ni-NTA superflow matrix (Qiagen), subsequent thrombin proteolysis of the His-tag followed by a subtractive IMAC step to remove uncleaved protein and a final gel filtration step on a preparative Superdex75 column (GE Healthcare) (CRELUX GmbH, Martinsried, Germany). The purified proteins were pure as judged by SDS-PAGE analysis and Coomassie staining. Polyclonal anti-human CCM2 and anti-human CCM3 sera were prepared through the immunization of rabbits with purified human CCM2 or CCM3 proteins coupled to keyhole limpet hemocyanin (immunoGlobe GmbH, Himmelstadt, Germany). Sera were affinity purified on columns consisting of non-tagged CCM2 or CCM3 protein covalently coupled to NHS-Sepharose 4FF beads. Western blot analyses of various tissue and cell lysates demonstrated that the anti-human CCM3 antibody reacted with a specific 25 kDa band as well as an additional 70 kDa protein representing Hsp70 and 30S ribosomal protein S1 as determined by mass spectrometry (data not shown). To get rid of these contaminations, epitope mapping of the 212 amino acid CCM3 sequence was carried out using PepSpotstrade mark technology (JPT Peptide Technologies GmbH, Berlin). Two libraries of 15mer peptides with eight or nine amino acids overlap revealed MIERPEPEFQDLNEK as a major epitope. In an alternative approach, a peptide corresponding to this sequence was used for purification of the anti-CCM3 antiserum yielding an affinity-purified antibody (IG-626; immunoGlobe GmbH, Himmelstadt, Germany) specific to human, murine, rat, chicken and Xenopus CCM3. The respective peptide from Danio rerio is not recognized by this antibody (data not shown). The PepSpotsTM technology was also applied for CCM2 epitope mapping. However, due to the extremely low yield of the peptide-purified anti-CCM3 antibody, this approach was not pursued for the anti-CCM2 antibody that proved to work specifically in immunohistochemical applications.
###end p 33
###begin title 34
Western blotting
###end title 34
###begin p 35
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C32">32</xref>
###xml 138 139 138 139 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 153 154 153 154 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 171 172 171 172 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C5">5</xref>
###xml 510 511 510 511 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 526 527 526 527 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 61 66 <span type="species:ncbi:10090">Mouse</span>
###xml 749 755 <span type="species:ncbi:9986">rabbit</span>
###xml 761 766 <span type="species:ncbi:9606">human</span>
Cell lysates were prepared as described by Voss et al. (32). Mouse tissues were homogenized in an iso-osmotic homogenization buffer (0.25 m sucrose, 10 mm Tris pH 7,2, 1 mm EDTA, Roche complete EDTA-free protease inhibitor) by five passes with 1000 U/min using a Potter S homogenizer (5). After a centrifugation step of 1000 r.p.m. for 2 min (rotor F45-30-11, eppendorf, Hamburg), the post-nuclear supernatants were frozen in liquid nitrogen. Cell lysates were prepared with lysis buffer (1% Triton-X-100, 10 mm Tris pH 8, 1 mm EDTA, Roche complete EDTA-free protease inhibitor). For western blot analysis, 10 microg of tissue and cell lysates were loaded onto 10-20% SDS-PAGE gels, electroblotted onto nitrocellulose and probed with the polyclonal rabbit anti-human CCM3 antibody at a dilution of 1 microg/ml. Secondary antibodies conjugated to peroxidase were purchased from Dianova.
###end p 35
###begin title 36
Immunohistochemistry
###end title 36
###begin p 37
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C33">33</xref>
###xml 384 385 380 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 386 387 382 383 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 713 715 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C16">16</xref>
###xml 451 455 <span type="species:ncbi:9925">goat</span>
###xml 486 491 <span type="species:ncbi:9606">human</span>
###xml 629 634 <span type="species:ncbi:9606">human</span>
###xml 658 663 <span type="species:ncbi:9606">human</span>
Immunohistochemistry was performed on neutral-buffered formalin-fixed and paraffin-embedded tissue slices as described before (33). Briefly, tissue sections (3 microm) were deparaffinized in xylene and rehydrated in graded alcohol. Antigen retrieval was performed in citrate buffer (pH 6.0) in a standard microwave oven for 10 min followed by blocking the endogenous peroxidase with H2O2 (3%) in methanol and blocking unspecific antibody binding with goat normal serum. Polyclonal anti-human CCM1 antibody (pAB anti-KRIT-1, Rb6832), a kind gift of Drs Marc Ginsberg and Angela Glading (University of California, San Diego), anti-human CCM2 antibody and anti-human CCM3 antibody were used at a dilution of 1:1000 (16) or concentrations of 16 and 6 microg/ml for immunohistochemistry, respectively. Antigen binding was visualized with the Histostain-Plus kit (Zymed Laboratories, South San Francisco, CA, USA).
###end p 37
###begin title 38
Laser-capture microdissection, WGA and mutation analyses
###end title 38
###begin p 39
Laser-capture microdissection of 10 microm CCM tissue sections was performed with a Leica LMD6000 microscope. Tissue slices were deparaffinized, rehydrated in graded alcohol and stained with 4,6-diamidino-2-phenylindole dihydrochloride at a concentration of 400 ng/ml for 10 min in order to visualize the nuclei of endothelial cells for microdissection.
###end p 39
###begin p 40
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C20">20</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C21">21</xref>
###xml 321 327 321 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1-3</italic>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN420C18">18</xref>
Genetic testing was approved by local Ethics Committees (University of Wurzburg, Study 21/05; Philipps-University Marburg, Study 149/05) and performed with informed consent. Published protocols were followed for DNA isolation of about 200 endothelial cells per tissue (20) and WGA by I-PEP-PCR (21). Subsequently, coding CCM1-3 exons including adjacent splice sites were directly sequenced on a Beckmann CEQ 8800 capillary electrophoresis system according to (18).
###end p 40
###begin title 41
SUPPLEMENTARY MATERIAL
###end title 41
###begin p 42
.
###end p 42
###begin title 43
FUNDING
###end title 43
###begin p 44
###xml 31 54 31 54 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bavarian Genome Network</grant-sponsor>
###xml 63 117 63 117 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Deutsche Forschungsgemeinschaft/Graduiertenkolleg 1048</grant-sponsor>
This work was supported by the Bavarian Genome Network and the Deutsche Forschungsgemeinschaft/Graduiertenkolleg 1048 (U.F. and S.S.). Funding to pay the Open Access charge was provided by the Bavarian Genome Network.
###end p 44
###begin title 45
Supplementary Material
###end title 45
###begin title 46
[Supplementary Data]
###end title 46
###begin title 47
ACKNOWLEDGEMENTS
###end title 47
###begin p 48
###xml 117 122 <span type="species:ncbi:9606">human</span>
We thank the affected individuals for participating in this study, Drs Marc Ginsberg and Angela Glading for the anti-human CCM1 antibody (pAB anti-KRIT-1, Rb6832), Dr Ismail Moarefi at CRELUX GmbH for comments on the manuscript, Gerhard Zimmermann at Leica microsystems for valuable support with the LMD and Heike Geissel and Sabine Gatzner for expert technical assistance.
###end p 48
###begin p 49
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. None declared.
###end p 49
###begin title 50
REFERENCES
###end title 50
###begin article-title 51
Cerebral cavernous malformation: new molecular and clinical insights
###end article-title 51
###begin article-title 52
Genetics of cavernous angiomas
###end article-title 52
###begin article-title 53
Intracerebral cavernous hemangioma after cranial irradiation in childhood. Incidence and risk factors
###end article-title 53
###begin article-title 54
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion
###end article-title 54
###begin article-title 55
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRIT1</italic>
Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1)
###end article-title 55
###begin article-title 56
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRIT1</italic>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
Search for loss of heterozygosity and mutation analysis of KRIT1 gene in CCM patients
###end article-title 56
###begin article-title 57
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccm1</italic>
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRIT1</italic>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations
###end article-title 57
###begin article-title 58
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
Molecular genetic investigations in the CCM1 gene in sporadic cerebral cavernomas
###end article-title 58
###begin article-title 59
###xml 97 105 <span type="species:ncbi:9606">patients</span>
Cerebral cavernomas in the adult. Review of the literature and analysis of 72 surgically treated patients
###end article-title 59
###begin article-title 60
Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development
###end article-title 60
###begin article-title 61
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD10</italic>
PDCD10, the gene mutated in cerebral cavernous malformation 3, is expressed in the neurovascular unit
###end article-title 61
###begin article-title 62
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRIT1</italic>
KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation
###end article-title 62
###begin article-title 63
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations
###end article-title 63
###begin article-title 64
Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations
###end article-title 64
###begin article-title 65
Ultrastructural pathological features of cerebrovascular malformations: a preliminary report
###end article-title 65
###begin article-title 66
KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell-cell junctions
###end article-title 66
###begin article-title 67
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ccm1</italic>
###xml 98 107 <span type="species:ncbi:7955">zebrafish</span>
ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish
###end article-title 67
###begin article-title 68
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM2</italic>
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM3</italic>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex
###end article-title 68
###begin article-title 69
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Genotype-phenotype correlations in cerebral cavernous malformations patients
###end article-title 69
###begin article-title 70
Whole genome amplification by improved primer-extension pre-amplified PCR
###end article-title 70
###begin article-title 71
Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa-significance of sampling
###end article-title 71
###begin article-title 72
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM</italic>
Clinical impact of CCM mutation detection in familial cavernous angioma
###end article-title 72
###begin article-title 73
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 38 43 <span type="species:ncbi:9606">child</span>
A novel CCM1 mutation in a 2-year old child. Cerebral and cutaneous manifetations of familial cavernoma
###end article-title 73
###begin article-title 74
Genetic causes of vascular malformations
###end article-title 74
###begin article-title 75
Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ('glomangiomas')
###end article-title 75
###begin article-title 76
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEK</italic>
Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations
###end article-title 76
###begin article-title 77
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
CCM1 gene deletion identified by MLPA in cerebral cavernous malformation
###end article-title 77
###begin article-title 78
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Large germline deletions and duplication in isolated cerebral cavernous malformation patients
###end article-title 78
###begin article-title 79
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM2</italic>
Deletions in CCM2 are a common cause of cerebral cavernous malformations
###end article-title 79
###begin article-title 80
###xml 50 53 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM</italic>
###xml 93 100 <span type="species:ncbi:9606">patient</span>
Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts
###end article-title 80
###begin article-title 81
Proliferating cell nuclear antigen (PCNA) in cerebral cavernomas: an immunocytochemical study of 42 cases
###end article-title 81
###begin article-title 82
CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations
###end article-title 82
###begin article-title 83
###xml 72 77 <span type="species:ncbi:9606">human</span>
Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness
###end article-title 83

